Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹19 Cr
P/E Ratio
--
P/B Ratio
3.84
Industry P/E
36.66
Debt to Equity
0
ROE
-8.21 %
ROCE
-7.95 %
Div. Yield
0 %
Book Value
7.31
EPS
-0.87
CFO
₹2.52 Cr
EBITDA
₹-0.82 Cr
Net Profit
₹-0.78 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| -42.12 | -10.18 | -40.48 | -22.78 | -1.42 | 14.91 | 9.34 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Phaarmasia
| 26.47 | 41.36 | -15.73 | -8.90 | 125.71 | 5.63 | -43.34 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 430.45 | 7,004.90 | 25.53 | 12.5 | |
| 5,218.00 | 8,680.23 | 36.69 | 43.77 | |
| 668.50 | 6,569.59 | 74.41 | 4.01 | |
| 745.45 | 6,001.20 | 34.39 | 20.28 |
No Review & Analysis are available.
Phaarmasia Limited manufactures and sells pharmaceutical products in India and internationally. It offers cosmetics, toothpastes, and oral contraceptive pills. The company was incorporated in 1981 and is based in Hyderabad, India.
Incorporated
1981
Chairman
--
Managing Director
--
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Phaarmasia Ltd stood at ₹ 27 Cr as on 31-Dec-24
The share price of Phaarmasia Ltd is ₹28.07 (BSE) as of 17-Apr-2025 IST. Phaarmasia Ltd has given a return of -1.42% in the last 3 years.
Phaarmasia Ltd has a market capitalisation of ₹ 19 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Phaarmasia Ltd is 3.84 times as on 17-Apr-2025, a 25% discount to its peers’ median range of 5.12 times.
Since, TTM earnings of Phaarmasia Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Phaarmasia Ltd and enter the required number of quantities and click on buy to purchase the shares of Phaarmasia Ltd.
Phaarmasia Limited manufactures and sells pharmaceutical products in India and internationally. It offers cosmetics, toothpastes, and oral contraceptive pills. The company was incorporated in 1981 and is based in Hyderabad, India.
The promoters of Phaarmasia Ltd are MANEESH PHARMACEUTICALS LIMITED and SVIZERA LABS PVT LTD. They collectively own 73.52 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Phaarmasia Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,577
|
|
|
6,871
|
|
|
6,260
|
|
|
5,723
|
| Phaarmasia Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-5.85
|
|
Operating margin(%)
|
-4.82
|
|
Net Margin(%)
|
-1.99
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Phaarmasia Ltd was ₹-1 Cr.
₹0.47
(
